FDA CLEARS GENTLEWAVES TO TREAT PERIORBITAL WRINKLES, RHYTIDS

Light BioScience has announced that the FDA cleared GentleWaves Light Emitting Diode (LED) Photomodulation System for the noninvasive treatment of periorbital -- eye area -- wrinkles and rhytids.

GentleWaves is the first and only LED device to receive marketing approval for a medical claim associated with cosmetic improvement of aging and sun-damaged skin, according to the company.

The device uses specially coded arrays of light emitting diodes to modulate the activity of living cells. GentleWaves' exclusive core technology delivers very low-intensity, nonthermal light energy to stimulate collagen and reverse the appearance of photoaging. With its proprietary and predetermined energy sequencing, the easy-to-use device poses no learning curve or risk of complications.